{"title": "Unexpected findings on SARS-CoV-2 replication", "author": null, "url": "https://www.helmholtz-hzi.de/en/press/videos-podcasts/videos/detail/", "hostname": "helmholtz-hzi.de", "description": "How SARS-CoV-2 initiates its replication process during infection is not yet fully understood. Researchers from the Helmholtz Institute W\u00fcrzburg (HIRI) have shown that it is the human protein SND1 which works together with the viral protein NSP9 to stimulate the virus\u2019s genetic replication program in infected cells.", "sitename": "Helmholtz Centre for Infection Research", "date": "2020-11-05", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Multimedia\nLive aus dem Lymphknoten\nDie Reaktion des Immunsystems auf eine Infektion birgt noch immer viele R\u00e4tsel. Bei der Immunantwort des K\u00f6rpers auf die eingedrungenen Bakterien spielen die wei\u00dfen Blutk\u00f6rperchen eine entscheidende Rolle. In den Lymphknoten informieren sie sich \u00fcber die Krankheitserreger. Dem Nachwuchswissenschaftler Matthias Gunzer ist es gelungen, diese Kommunikation live zu beobachten. L\u00e4nge: 6:12\nHerzkrank durch Karies\nKarieserreger sch\u00e4digen nicht nur die Z\u00e4hne. Sie k\u00f6nnen auch f\u00fcr eine Reihe anderer schwerer Erkrankungen ausl\u00f6sen. Diese Gefahr wird oft untersch\u00e4tzt. Gelangen sie bei einer Zahnoperation in den Blutkreislauf, k\u00f6nnen sie Blutvergiftungen und Herzklappenentz\u00fcndungen hervorrufen. Der Infektionsforscher Prof. Dr. Singh Chhatwal will herausfinden, was die Bakterien so gef\u00e4hrlich macht. L\u00e4nge: 05:58\nSchnupfimpfung\nImpfen ohne Spritze. Darauf warten nicht nur Spritzen-Phobiker. Nasensprays sollen in Zukunft das Impfen revolutionieren. Doch es gibt ein gro\u00dfes Problem: Der Impfstoff muss zuerst durch die wehrhafte Schleimhaut, um zu seinem Ziel zu gelangen. Der L\u00f6sung dieses Problems hat sich ein Forscherteam des Helmholtz-Zentrums f\u00fcr Infektionsforschung mit gro\u00dfem Erfolg verschrieben. L\u00e4nge: 05:59\nEpothilon: Ein HZI-Molek\u00fcl wird zum Krebsmedikament\nWissenschaftler an der ehemaligen Gesellschaft f\u00fcr Biotechnologische Forschung (\n[GBF](/en/info-centre/glossary/entry/gbf/)), dem heutigen HZI, haben in den 1980er Jahren Epothilon B entdeckt. Dieser Naturstoff st\u00f6rt die Teilung von Krebszellen: Tumore werden durch ihn im Wachstum gebremst, schrumpfen und verschwinden. Das Pharmaunternehmen Bristol-Myers Squibb (BMS) hat jetzt auf der Basis von Epothilon B ein Krebsmedikament auf den US-amerikanischen Markt gebracht. Seine Entwicklung ist so spannend wie ein Krimi...\nL\u00e4nge: 11:34\nImpfung gegen Diabetes\nDiabetes mellitus ist inzwischen eine Volkskrankheit an der j\u00e4hrlich mehr junge Menschen erkranken. Lebenslang m\u00fcssen die Betroffenen strenge Di\u00e4t halten und Insulin spritzen, da ihre Bauchspeicheldr\u00fcse das Hormon nicht produziert und dadurch der Zucker im Blut nicht von den Zellen aufgenommen werden kann. Diabetes ist eine Krankheit, bei der das Immunsystem selbst f\u00fcr die Krankheit verantwortlich ist. Forscher am HZI versuchen die Krankheit zu verstehen und haben in M\u00e4usen einen Weg gefunden das Immunsystem auszutricksen: Sie programmieren es um. Der erste Schritt zu einer v\u00f6llig neuen Therapie.\nL\u00e4nge: 06:08\nDoppelt aktiviert besser\nBakterien ist jedes Mittel recht, um einen Organismus zu infizieren. Sie dringen in Zellen ein, wandern durch den K\u00f6rper, t\u00e4uschen das Immunsystem oder missbrauchen Abl\u00e4ufe der Wirtszelle f\u00fcr ihre Zwecke. Jedes Bakterium hat dabei seine eigene Methode. Welche Mechanismen Listeria-Bakterien nutzen, haben jetzt Strukturbiologen des Helmholtz-Zentrums f\u00fcr Infektionsforschung (HZI) in Braunschweig herausgefunden. Der Trick der Erreger: Sie binden mit zwei Invasionsproteinen an einen Rezeptor auf menschlichen Zellen und lassen sich in die Zelle einschleusen. Diese Eintrittskarte ist eigentlich f\u00fcr Faktoren reserviert, die das Zellwachstum und die Wundheilung steuern. Sehen Sie, wie Professor Dirk Heinz und seine Arbeitsgruppe den Bakterien auf die Spur gekommen sind\u2026\nL\u00e4nge 06:15\nSteriles Beutelsystem\nIm HZI z\u00fcchten die Wissenschaftler Kurt Dittmar und Werner Lindenmaier Zellen, die extrem empfindlich sind. Sie sollen f\u00fcr therapeutische Zwecke eingesetzt werden und um den Umgang mit diesen Zellen zu vereinfachen, haben die Wissenschaftler ein Beutelsystem entwickelt, in dem die Zellen in kleinen durchsichtigen Kunststoffbeuteln fest verschlossen sind. Darin k\u00f6nnen die Zellen kultiviert, sortiert, gereinigt werden. Damit die Zellen in unserem Beutel vern\u00fcnftig wachsen k\u00f6nnen, muss er beschichtet werden. L\u00e4nge: 07:17\nPaper of the month December 2013 (in German)\nJeden Monat zeichnet das HZI Nachwuchswissenschaftler mit dem Preis \u201ePaper of the Month\" f\u00fcr eine herausragende Publikation aus. Im Dezember wurden Bastian Hatesuer und Nora Mehnert, f\u00fcr ihre Ver\u00f6ffentlichung \"Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice\" im Journal Plos Pathogens, ausgezeichnet. Woran die beiden forschen, erkl\u00e4ren Sie in diesem Videopodcast.. L\u00e4nge 05:45\nHZI International Graduate School\nThe International HZI Graduate School, Grad School for short, offers young researchers from all over the world the opportunity to obtain a PhD degree. Watch the image video of the Grad School to find out which conditions the students can expect at the HZI, how important internationality is and that there is leisure besides research as well. Length 01:54\nKrankheitsErregend - Impfung\nNoch vor wenigen Jahrzehnten waren die Pocken eine weit verbreitete, oft t\u00f6dliche Seuche. Heute gelten sie weltweit als ausgerottet. Diese Erfolgsgeschichte geht auf eine der wirksamsten vorbeugenden Ma\u00dfnahmen der Medizin zur\u00fcck: die Impfung. Diese bef\u00e4higen das Immunsystem, Krankheitserreger zu eliminieren, noch bevor es zu einem Krankheitsausbruch kommt. Im ersten Teil der Vortragsreihe \u201eKrankheitsErregend \u2013 Meilensteine der Medizin\u201c beleuchteten Marion Hulverscheidt, Carlos A. Guzm\u00e1n und Hans Georg Koch das Thema aus verschiedenen Blickwinkeln.\nKrankheitsErregend - Antibiotika\nZufall und Unordnung im Labor f\u00fchrten dazu, dass der schottische Wissenschaftler Sir Alexander Fleming 1928 eine Wunderwaffe gegen bakterielle Infektionskrankheiten entdeckte. Das von einem Schimmelpilz hergestellte Penicillin hindert Bakterien am Wachsen und wurde erfolgreich als erstes Antibiotikum eingesetzt. Danach fanden Forscher weitere, von Mikroorganismen produzierte Stoffe, die f\u00fcr Bakterien giftig sind. Sie z\u00e4hlen zu den effektivsten Mitteln gegen bakterielle Infektionen. Durch h\u00e4ufigen Antibiotika-Einsatz sind heutzutage viele Mikroorganismen resistent gegen die Medikamente. Im Rahmen der zweiten Veranstaltung der Vortragsreihe \u201eKrankheitsErregend \u2013 Meilensteine der Medizin\u201c ging es sowohl um die Geschichte des Wundermittels als auch um die heutige Forschung und die Probleme in der klinischen Praxis.\nS3-Labor\nIm Labor der biologischen Schutzstufe 3 auf dem Campus des HZI k\u00f6nnen unsere Wissenschaftler Krankheitserreger erforschen, die schwere Krankheiten verursachen \u2013 beispielsweise FSME-Viren oder\n[EHEC](/en/info-centre/glossary/entry/ehec/)-Bakterien. Laboranlagen der Schutzstufe S3 sind gegen\u00fcber der Au\u00dfenwelt abgeschlossene isolierte Anlagen, sogenannte \u201eContainments\u201c. Nur wenige fachkundige Wissenschaftler am HZI haben Zutritt zu diesem Labor, aber dieser Film erm\u00f6glicht einen Blick hinter die Kulissen des S3-Labors.\nKrankheitsErregend - Transplantation\nSeitdem im Jahr 1954 das erste Organ \u2013 eine Niere \u2013 verpflanzt wurde, hat sich die Transplantationsmedizin weiterentwickelt. In vielen Bereichen hat sie sich bew\u00e4hrt und ist heute eine Standardtherapie. Die Transplantation mit ihren M\u00f6glichkeiten, Grenzen und Zukunftsperspektiven war das Abschlussthema der Reihe \u201eKrankheitsErregend \u2013 Meilensteine der Medizin\u201c am HZI. In dieser Audioslideshow haben wir Eindr\u00fccke von der Veranstaltung f\u00fcr Sie gesammelt. Treten Sie also ein in die Welt der Transplantation\u2026\nMolekulare Bakteriologie\nProf. Susanne H\u00e4u\u00dfler leitet die Abteilung Molekulare Bakteriologie am HZI. Sie und ihr Team suchen nach genetischen Merkmalen, mit denen sie Antibiotika-Resistenzen von Bakterien schneller erkennen k\u00f6nnen. Insbesondere erforschen die Wissenschaftler den Krankenhauskeim\n[. Pseudomonas aeruginosa](/en/info-centre/glossary/entry/pseudomonas-aeruginosa/)\nPaper of the Month Januar 2015\nJeden Monat zeichnet das HZI Nachwuchswissenschaftler mit dem Preis \u201ePaper of the Month\" f\u00fcr eine herausragende Publikation aus. Diesmal ging der Preis an Catharina Arnold-Schrauf. Ihre Ver\u00f6ffentlichung \u201eDendritic Cells Coordinate Innate Immunity via MyD88 Signaling to Control Listeria monocytogenes Infection\" erschien in \u201eCell Reports\". Woran sie forscht, erkl\u00e4rt Sie in diesem Videopodcast.\nHIPS Infofilm\nDie Zunahme von Antibiotika-Resistenzen ist ein ernsthaftes medizinisches Problem: Immer \u00f6fter breiten sich Krankheitskeime ungehindert aus. Die Entwicklung neuer Wirkstoffe basiert derzeit haupts\u00e4chlich immer noch\nauf Wirkmechanismen und alten Molek\u00fclstrukturen, die schon lange bekannt sind. Neue Strategien sind n\u00f6tig, um neuartige anti-infektive Wirkstoffe zu entdecken und weiterzuentwickeln. Hier setzt das Helmholtz-Institut f\u00fcr Pharmazeutische Forschung Saarland (HIPS) an.\nMerry Christmas\nThe Helmholtz Centre for Infection Research would like to wish a Merry Christmas and a good start into the new year to everyone with a little video.\nMusic: Daniel Melching\nPaper of the Month Februar 2015\nDas \"Paper of the Month\" geht im Februar 2015 an eine Gemeinschaftsproduktion der HZI-Abteilung Vakzinologie und der Abteilung Wirkstoff-Transport des HIPS f\u00fcr die Ver\u00f6ffentlichung des Papers \u201eInverse micellar sugar glass (IMSG) nanoparticles for transfollicular\n[vaccination](/en/info-centre/glossary/entry/vaccination/)\u201c im Journal of Controlled Release. Entgegengenommen wurde der Preis von HZI-Wissenschaftler Kai Schulze.\nPaper of the Month M\u00e4rz 2015\nGewinner des \"Paper of the Month\" f\u00fcr den Monat M\u00e4rz 2015 ist Aaron Mischa Nuss, Postdoc in der Molekularen Infektionsbiologie am HZI. Er erh\u00e4lt den Preis f\u00fcr sein in PLoS Genetics ver\u00f6ffentlichtes Paper \"Transcriptomic profiling of\n[Yersinia](/en/info-centre/glossary/entry/yersinia/) pseudotuberculosis reveals reprogramming of the Crp regulon by temperature and uncovers Crp as a master regulator of small RNAs\". \u00dcbergeben wurde der Preis von Melanie Brinkmann, Leiterin der Abteilung Virale Immunmodulation.\nPaper of the Month April 2015\nAndrea Blanka, from the Institute Molecular Bacteriology, was awarded \"Paper of the Month\" for April 2015. Her paper \"Constitutive production of c-di-GMP is associated with mutations in a variant of\n[ with altered membrane composition\" was published in Science Signaling. Melanie Brinkmann, head of the department Viral Immune Modulation, handed over the award. Find out more about her research in this videopodcast. Pseudomonas aeruginosa](/en/info-centre/glossary/entry/pseudomonas-aeruginosa/)\nPaper of the Month Mai 2015\nThe prize \"Paper of the Month\" for May 2015 was awarded to Angga Kusuma from the department Experimental Virology at Twincore in Hannover. His publication \"\n[Interferon](/en/info-centre/glossary/entry/interferon/)-inducible cholesterol-25-hydroxylase restricts [hepatitis](/en/info-centre/glossary/entry/hepatitis/) C virus replication via blockage of membranous web Formation\" was released in the journal Hepatology. Learn more about his reserach in this videopodcast.\nMaking-of: The \"50\"\nCutting-edge research in the heart of Braunschweig - that's what our research campus stands for since 50 years! Braunschweig and the HZI belong together and that's why we went on a little \u201c50\u201d tour throughout the Lion City. The video shows how the \"50\" was built and how it explored various famous sights in the city.\n9th J\u00fclich Lecture: Targetting edpidemics\nTalk by Prof. Krause in J\u00fclich about the SORMAS project.\nHZI-History as told in pictures\nThe history of the Helmholtz Centre for Infection Research illustrated through drawings by Marcia Duarte, scientist at the HZI.\nPaper of the month Juni 2015\nThe prize \"Paper of the Month\" for June 2015 was awarded to Angela Kling from the department Mikrobielle Naturstoffe at HIPS in Saarbr\u00fccken. The prize was handed to Peer Lukat, the other first author of the paper, because Andrea Kling was not present at the day. Her publication \"Targeting DnaN for\n[tuberculosis](/en/info-centre/glossary/entry/tuberculosis/) therapy using novel griselimycins\" was released in the journal Science. Find out more about their research in this videopodcast.\nPaper of the month Juli 2015\nThe prize \"Paper of the Month\" for July 2015 was awarded to Gisa Gerold from the Twincore in Hannover. Her publication \"Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry\" was released in Cell Reports. Learn more about her research in this videopodcast.\nPaper of the month September 2015\nThe prize \"Paper of the Month\" for September 2015 was awarded to Michael Reck from the Group Microbial Communication. It was handed over by Denitsa Eckweiler. The publication \"The Alternative Sigma Factor SigX Controls Bacteriocin Synthesis and Competence, the Two Quorum Sensing Regulated Traits in\n[Streptococcus mutans](/en/info-centre/glossary/entry/streptococcus-mutans/)\" was released in PLOS Genetics. In this videopodcast Michael Reck explains what he is working on.\nSORMAS - the future of epidemic surveillance\nEpidemiologists and IT experts from Germany and Nigeria have jointly developed an innovative app to help fight epidemics like ebola or\n[cholera](/en/info-centre/glossary/entry/cholera/) - the Surveillance Outbreak Response Management and Analysis System (SORMAS). This video explains why a tool like SORMAS is urgently needed and introduces the unique approach that makes SORMAS so powerful.\n50 years HZI - Present\nThe Helmholtz Centre for Infection Research conducts application-oriented fundamental research. The three main research topics are \"Bacterial and Viral Pathogens\", \"Immune Response\" and \"Anti-Infectives\". But what does this mean for the work of the HZI scientists? The film \"present\u201d takes a look behind the scenes and gives an impression of everyday life of a modern research center.\n50 years HZI - Politics\nCutting-edge research without money and support is impossible. The policy establishes framework conditions, which allow the HZI to fulfill its research mission. The film \"politics\" shows, what is important in the complex interaction between science and politics.\n50 years HZI - Past\nThe HZI can look back on a 50-year history full of successes. In the anniversary film \"Past\" longstanding HZI employees report about their experiences at the HZI centre and its former institutions.\n50 years HZI - Translational Research\nTranslational research is one of the main research topics at the HZI. Its function is to connect the laboratory with the clinics. But what is\n[translation](/en/info-centre/glossary/entry/translation/) and why is it so important for the HZI? This question is answered in the the film \"Translational Research\" from the 50-year anniversary film series.\n50 years HZI - Future\nThe fight against infectious diseases will remain acute in the coming years. Pathogens spread rapidly, adapt to the\n[immune system](/en/info-centre/glossary/entry/immune-system/) and on medications and evolve constantly. Therefore, [infection](/en/info-centre/glossary/entry/infection/) research has to evolve constantly too. In the film \"future\", which was filmed as part of our 50th anniversary, experts from research and politics talk about the possible directions the HZI could take and try to give an outlook into the future of [infection](/en/info-centre/glossary/entry/infection/) research at the HZI and in the world.\nPaper of the month October 2015\nThe prize \"Paper of the Month\" for October 2015 was awarded to Ren\u00e9 Lesnik from the Group Microbial Diagnostics. The publication \"Legionella species diversity and dynamics from surface reservoir to tap water: from cold adaptation to thermophily\" was released in \"The ISME Journal\". In this videopodcast Ren\u00e9 Lesnik explains what he is working on.\nPaper of the month November 2015\nThe prize \"Paper of the Month\" for November 2015 was awarded to Simon Sebastian R\u00e4sch from the Department of Drug Delivery at HIPS in Saarbr\u00fccken. The publication \"Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition\" was released in ACS Nano.\nPaper of the month December 2015\nThe prize \"Paper of the Month\" for December 2015 was awarded to Markus Dudek from the Department of Infection Immunology at the Twincore in Hanover. The publication \"Lung epithelium and myeloid cells cooperate to clear acute pneumococcal\n[infection](/en/info-centre/glossary/entry/infection/)\" was released in Mucosal Immunology.\nHIPS Infofilm (English)\nResistance to antibiotics has become one of the major global challenges regarding infectious diseases. This is specifically the issue that is being tackled by the new Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS).\nMolecular Trojan Horses Visualize Infections\nResearchers from the Helmholtz Centre for Infection Research (HZI) and the German Center for Infection Research (DZIF) recently developed molecular probes that utilise the iron transport system of\n[bacteria](/en/info-centre/glossary/entry/bacteria/) to transport antibacterial agents into the bacterial cell. These \"molecular Trojan horses\" can also carry fluorescence markers and thus make infections in smaller animals visible and amenable to treatment. Kevin Ferreira explains here the new developed method in a minute.\nFighting epidemics in Nigeria with SORMAS-App\nGerman scientists from the Helmholtz Centre for Infection Research (HZI) and the German Center for Infection Research (DZIF) in Braunschweig and Nigerian researchers are applying the new mobile information system for the first time to combat a monkeypox outbreak in Nigeria. The monkeypox\n[epidemic](/en/info-centre/glossary/entry/epidemic/) has spread since September 2017 and, by now, afflicts 128 patients in 14 federal states in Nigeria. The name of the system, SORMAS, stands for \"Surveillance, Outbreak Response Management and Analysis System\".\nWe market ideas - With Ascenion in seven steps from idea to innovation\nAscenion GmbH is a technology transfer company and supports the further development and marketing of its research results. In this video, innovation manager Petra K\u00f6hler and senior technology manager Sabina Heim present the steps necessary for successful licensing.\nVideo showing the mobility of PqsBC\nPqsBC exists in different conformational states. Computer simulations can be used to derive a dynamic mechanism from these states, in which PqsBC can bind to the fatty acid chain by closing the molecule.\nForming of an immunological synapse\nThe\n[immune system](/en/info-centre/glossary/entry/immune-system/) protects the human body against pathogens thus keeping it healthy. To achieve this, however, immune cells must be able to recognise intruders and to classify them as dangerous or harmless. These tasks are shared among different cell types: If an immune cell recognises foreign matter, it can present it to another immune cell. Both cells form a characteristic ring-shaped structure at their contact point, the immunological synapse, through which they exchange information. If all the components of the synapse are correctly positioned, activation of the immune cell will result.\nMelanoma cell migration driven by WAVE complex (green) and actin filaments (red). Elapsing time is in minutes and seconds.\nVarious bacterial pathogens stimulate their hosts to engulf them during\n[infection](/en/info-centre/glossary/entry/infection/) processes, allowing the [bacteria](/en/info-centre/glossary/entry/bacteria/) to gain access to the [host](/en/info-centre/glossary/entry/host/) cell cytoplasm. This occurs through manipulation of dynamic, but force-bearing cellular [protein](/en/info-centre/glossary/entry/protein/) scaffolds, allowing the pathogens to firmly adhere to, invade or spread within [host](/en/info-centre/glossary/entry/host/) cells. A [protein](/en/info-centre/glossary/entry/protein/) complex termed WAVE complex that can bind to regulatory switches, so-called small GTPases, has been ascribed a key role in such processes.\nMetastasis-forming cancer cell with lamellipodia\nVarious bacterial pathogens stimulate their hosts to engulf them during\n[infection](/en/info-centre/glossary/entry/infection/) processes, allowing the [bacteria](/en/info-centre/glossary/entry/bacteria/) to gain access to the [host](/en/info-centre/glossary/entry/host/) cell cytoplasm. This occurs through manipulation of dynamic, but force-bearing cellular [protein](/en/info-centre/glossary/entry/protein/) scaffolds, allowing the pathogens to firmly adhere to, invade or spread within [host](/en/info-centre/glossary/entry/host/) cells. A [protein](/en/info-centre/glossary/entry/protein/) complex termed WAVE complex that can bind to regulatory switches, so-called small GTPases, has been ascribed a key role in such processes.\nWhy Personalized Medicine Matters\nWhy Personalized Medicine Matters\" by Edward Abrahams Ph D (Personalized Medizine Coaliation) at Herrnhausen Symposium 2018.\nHow may individualisation find its way into care of patients with infectious diseases? This hot topic was discussed during the international Herrenhausen Symposium on June 21-23, 2018, in Hannover. The symposium aimed at fostering international and interdisciplinary collaboration by bringing together outstanding experts from different fields to address major scientific questions, tackle ethical, social and economical considerations and discuss the requirements for regulation processes in individualised medicine.\nThe Journey of Personalized Healthcare into Digital Era - An Industry perspective\n\"The Journey of Personalized Healthcare into the Digital Era - An industry perspective\" by Prof Dr Hagen Pfundner (Roche Pharma AG) at Herrenhausen Symposium 2018.\nHow may individualisation find its way into care of patients with infectious diseases? This hot topic was discussed during the international Herrenhausen Symposium on June 21-23, 2018, in Hannover. The symposium aimed at fostering international and interdisciplinary collaboration by bringing together outstanding experts from different fields to address major scientific questions, tackle ethical, social and economical considerations and discuss the requirements for regulation processes in individualised medicine.\nSurface of the enzyme PurAH\nThe surface of the enzyme PurAH with the two catalytic zinc ions (grey spheres) bound at the active site.\n3D model of the enzyme BotH\nIn bottromycin, a potential antibiotic,\n[bacteria](/en/info-centre/glossary/entry/bacteria/) build up a mirrored [amino acid](/en/info-centre/glossary/entry/amino-acid/). In a study published in the journal Nature Chemical Biology, Jesko K\u00f6hnke, head of the junior research group \"Structural Biology of Biosynthetic Enzymes\" at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), describes the enzyme BotH which is necessary for this.\nHow to stop the coronavirus with the Cheesemodel\nVirologist Prof Melanie Brinkmann compares measures against the coronavirus with swiss cheese. No measure is perfect but many measures together could be the key to success.\nMuSPAD - the nationwide antibody study of the HZI on the spreading of SARS-CoV-2 infections\nHow many people in Germany have already been infected with the coronavirus\n[SARS](/en/info-centre/glossary/entry/sars/)-CoV-2 and how is the [pandemic](/en/info-centre/glossary/entry/pandemic/) developing? These and other questions are being investigated by the Helmholtz Centre for Infection Research with the MuSPAD project (Multilocal and Serial cross-sectional Prevalence Study on Antibodies against [SARS](/en/info-centre/glossary/entry/sars/)-CoV-2 in Germany). In different regional samples, blood is taken from selected volunteers and tested for [SARS](/en/info-centre/glossary/entry/sars/)-CoV-2 [antibodies](/en/info-centre/glossary/entry/antibodies/).\nIn the video, HZI scientists explain the study design, as well as the procedure & objectives of the project.\nNovel COVID testing method\nCRISPR discovery from W\u00fcrzburg paves the way for LEOPARD\nAm I infected with\n[SARS](/en/info-centre/glossary/entry/sars/)-CoV-2? Is it one of the dangerous variants? Being able to answer these and more questions with a single efficient diagnostic test can be decisive for gauging the spread of disease and selecting the right therapy. In a study published today in the journal \"Science\", researchers from W\u00fcrzburg at the Helmholtz Institute for [RNA](/en/info-centre/glossary/entry/rna/)-based Infection Research (HIRI), a site of the Helmholtz Centre for Infection Research (HZI) in cooperation with the Julius Maximilians University (JMU), tackle this challenge with a new CRISPR discovery they translated into a diagnostic platform called LEOPARD.\nHow is the HZI contributing to the management of the coronavirus pandemic?\nSince the beginning of the\n[SARS](/en/info-centre/glossary/entry/sars/)-CoV-2 [pandemic](/en/info-centre/glossary/entry/pandemic/), the Helmholtz Centre for Infection Research (HZI) in Braunschweig has focused its research activities on the novel coronavirus. Representative for the diverse research projects at HZI, three scientists present their contributions to coping with the [pandemic](/en/info-centre/glossary/entry/pandemic/). Prof Michael Meyer-Hermann is developing mathematical models for the course of the [pandemic](/en/info-centre/glossary/entry/pandemic/). Prof Melanie Brinkmann has investigated transmission pathways in a large coronavirus outbreak and shown that the pathogen can be spread via aerosols. Prof G\u00e9rard Krause is leading an antibody study to monitor the development of the [pandemic](/en/info-centre/glossary/entry/pandemic/) and is developing digital tools such as the SORMAS system to support the public health service in [pandemic](/en/info-centre/glossary/entry/pandemic/) response.\nGreeting by Dr Chikwe Ihekweazu (WHO) at the founding ceremony of the Helmholtz Institute for One Health\nVideo message from Dr. Chikwe Ihekweazu, Deputy Director-General of the World Health Organization (\n[WHO](/en/info-centre/glossary/entry/who/)), on the occasion of the ceremonial founding of the Helmholtz Institute for One Health (HIOH) in Greifswald on 26 April 2022.\nStefanie Drese at the founding ceremony of the Helmholtz Institute for One Health\nVideo message from Stefanie Drese, Minister for Social Affairs, Health and Sport, on the occasion of the ceremonial founding of the Helmholtz Institute for One Health (HIOH) in Greifswald on 26 April 2022.\nProf Lothar Wieler (RKI) on the founding ceremony of the Helmholtz Institute for One Health\nMessage of greeting from Prof. Lothar Wieler, President of the Robert Koch Institute (RKI), on the occasion of the ceremonial founding of the Helmholtz Institute for One Health (HIOH) in Greifswald on 26 April 2022.\nMessage of greeting from Patrick Dahlemann on the occasion of the founding ceremony of the Helmholtz Institute for One Health\nGreeting by Patrick Dahlemann, Head of the State Chancellery of Mecklenburg-Vorpommern, on the occasion of the ceremonial founding of the Helmholtz Institute for One Health (HIOH) in Greifswald on 26 April 2022.\n1 cure for ALL viruses? 6 new research teams in the challenge by the Federal Agency for Disruptive Innovations [Video in German]\nSix research teams have entered the second phase of the SPRIND Challenge \"A Quantum Leap for New Antiviral Agents\" with their approach to developing new antiviral agents. Scientists from the Helmholtz Centre for Infection Research are involved in three of the funded projects. YouTuber Jacob Beautemps introduces the teams.\nHow do researchers at the HZI and HIPS develop antibiotic candidates from natural products?\nHow do researchers at the HZI and HIPS develop a new antibiotic?\nClose your Data Gap with LBDS\nThe low-bandwidth database synchronization technology - LBDS - was invented by Prof G\u00e9rard Krause, department head at the Helmholtz Centre for Infection Research (HZI), to ensure data-based synchronization in remote areas with very poor internet connectivity. It secures data transmission regardless from the working environment from every place in the world using whatever information channel is available, be it mobile or satellite connection. Close your data gap with LBDS.\nJosef Penninger, Geneticist and Visionary, becomes the New Scientific Director of the HZI\nOn July 1, 2023, Prof. Dr. Josef Penninger will take over as Scientific Director of the Helmholtz Centre for Infection Research (HZI). The geneticist has received many international awards for his outstanding contributions to genetics and molecular biology. His vision for the HZI is simple: \"You have to know what you want to be. We want to be the best research institute for\n[infection](/en/info-centre/glossary/entry/infection/) biology in the world!\u201d\nHZI enters the future with a new scientific director\nThe global progression of infectious diseases is constantly challenging the world's medical and societal needs. With pioneering research approaches such as personalized medicine, digital solutions for global health, and innovative drug research, the Helmholtz Centre for Infection Research is paving the way for the future, as July 1st, 2023 under the leadership of its new scientific director Prof. Josef Penninger.\nUnexpected findings on SARS-CoV-2 replication\nHow\n[SARS](/en/info-centre/glossary/entry/sars/)-CoV-2 initiates its replication process during [infection](/en/info-centre/glossary/entry/infection/) is not yet fully understood. Researchers from the Helmholtz Institute W\u00fcrzburg (HIRI) have shown that it is the human [protein](/en/info-centre/glossary/entry/protein/) SND1 which works together with the viral [protein](/en/info-centre/glossary/entry/protein/) NSP9 to stimulate the virus\u2019s genetic replication program in infected cells.\nNews\n[Send per email](mailto:?subject=&body=https://www.helmholtz-hzi.de/en/press/videos-podcasts/videos/detail/article/-fccb893ff2/72/)Share", "language": null, "image": null, "pagetype": null, "links": ["/en/", "/de/presse/videos-podcasts/videos/detail/article/-fccb893ff2/72/", "/en/the-hzi/", "/en/the-hzi/about-the-hzi/facts-and-figures/", "/en/the-hzi/about-the-hzi/the-hzi/", "/en/the-hzi/about-the-hzi/facts-and-figures/", "/en/the-hzi/about-the-hzi/research-reports/", "/en/the-hzi/about-the-hzi/history-1965-2006/", "/en/the-hzi/about-the-hzi/history-since-2006/", "/en/the-hzi/management/executive-management/", "/en/the-hzi/administration-infrastructure/", "/en/the-hzi/organisation-chart/", "/en/the-hzi/sites/", "/en/the-hzi/360-tour/", "/en/the-hzi/helmholtz-association/", "http://helmholtz-hzi.bibliotheca-open.de/Welcome", "/en/the-hzi/conference-building/", "/en/the-hzi/friends-of-the-hzi/", "/en/the-hzi/mission-statement/", "/en/the-hzi/gender-equality/gender-equality/", "/en/the-hzi/conflict-resolution/", "/en/the-hzi/donation/", "/en/research/research-topics/", "/en/research/mission/", "/en/research/our-research/", "/en/research/research-topics/", "/en/research/research-topics/bacterial-and-viral-pathogens/", "/en/research/research-topics/immune-response/", "/en/research/research-topics/anti-infectives/", "/en/research/research-foci/", "/en/research/research-foci/antimicrobial-resistance-amr/", "/en/research/research-foci/microbial-communities-mico/", "/en/research/research-foci/chronic-viral-infections-cvir/", "/en/research/research-foci/individualized-immune-interventions-indi/", "/en/research/research-foci/digital-and-global-health-epi/", "/en/research/research-foci/infection-and-neurodegeneration-ineu/", "/en/research/research-foci/respiratory-viral-infections-rvir/", "/en/research/research-groups/", "/en/research/technology-platforms/", "/en/research/innovation-management/", "/en/research/cooperations/research-partners/", "/en/research/publication-database/", "/en/research/good-scientific-practice/", "/fileadmin/user_upload/Infothek/Roadmap_HZI_2025/Roadmap_engl_2016_WEB_ES.pdf", "/en/research/translational-research/", "/fileadmin/user_upload/Infothek/Ueber_das_HZI/Jahresberichte/Ergebnisberichte/WEB_HZI_RReport_2022_9MB.pdf", "/fileadmin/user_upload/Infothek/Ueber_das_HZI/Jahresberichte/Ergebnisberichte/WEB_HZI_RReport_2022_9MB.pdf", "/en/career/", "/en/career/jobs/open-positions/", "/en/career/jobs/open-positions/", "/en/career/jobs/phd-theses/", "/en/career/jobs/bachelor-and-master-thesis/", "/en/career/career-paths/", "/en/career/graduate-school/application/", "/en/career/phd-programme-epidemiology/objectives/", "/en/career/embl-hzi-fellowship/general-information/", "/en/career/hzi-mcgill-exchange-program/about-the-program/", "/en/career/do-it-phd-initiative/what-we-do/", "/en/career/hzi-alumni/aims/", "/en/career/pupils/apprenticeships/", "/en/career/career-paths/", "/en/press/", "/en/press/press-releases-news/", "/en/press/gallery-download/", "/en/press/press-kit-josef-penninger/", "/en/press/media-coverage/", "/en/service/newsletter/", "/en/press/press-contacts/", "/en/press/videos-podcasts/videos/", "/en/press/magazine-infact/recent-issue/", "/en/press/brochures/", "/en/press/visitors-service/", "/en/press/press-kit-josef-penninger/", "/en/press/press-kit-josef-penninger/", "/en/info-centre/", "/en/info-centre/topics/all-topics/", "/en/info-centre/topics/germs-and-diseases/", "/en/info-centre/topics/our-immune-system/", "/en/info-centre/topics/anti-infectives/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/", "/en/info-centre/topics/germs-and-diseases/coronaviruses/", "/en/news-events/", "/en/news-events/news/", "/en/news-events/events/", "/en/news-events/research-awards/paper-of-the-month/", "/en/news-events/projects/", "/en/news-events/projects/discourse-animals-in-research/", "/en/news-events/stories/", "/en/news-events/stories/world-day-for-laboratory-animals-and-alternative-models/", "/en/news-events/stories/world-antibiotic-awareness-week-2022/", "/en/news-events/stories/one-health-triad-of-environmental-animal-and-human-health/", "/en/news-events/interview/", "/en/news-events/interview/martin-korte-long-covid-can-become-manifest-even-after-a-mild-course-of-covid-19/", "/en/news-events/interview/peggy-riese-the-corona-vaccines-were-meant-to-protect-against-severe-disease-and-that-is-what-they-do/", "/en/news-events/portrait/", "/en/news-events/portrait/christian-sieben-a-biologist-with-nano-vision/", "/en/news-events/portrait/susanne-talay-a-little-outbreak-every-day/", "/en/news-events/portrait/antoine-emmanuel-saliba-shining-a-spotlight-on-the-cellular-mechanism/", "/en/news-events/stories/coronavirus-sars-cov-2/", "/en/news-events/stories/coronavirus-sars-cov-2/", "/en/", "/en/press/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/#anchorsection", "/en/press/videos-podcasts/podcasts/#anchorsection", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/gbf/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/ehec/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/pseudomonas-aeruginosa/", "/en/info-centre/glossary/entry/pseudomonas/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/vaccination/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/yersinia/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/pseudomonas-aeruginosa/", "/en/info-centre/glossary/entry/pseudomonas/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/interferon/", "/en/info-centre/glossary/entry/hepatitis/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/tuberculosis/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/streptococcus-mutans/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/cholera/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/translation/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/immune-system/", "/en/info-centre/glossary/entry/infection/", "/en/info-centre/glossary/entry/infection/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/infection/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/bacteria/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/epidemic/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/immune-system/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/infection/", "/en/info-centre/glossary/entry/bacteria/", "/en/info-centre/glossary/entry/host/", "/en/info-centre/glossary/entry/protein/", "/en/info-centre/glossary/entry/host/", "/en/info-centre/glossary/entry/protein/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/infection/", "/en/info-centre/glossary/entry/bacteria/", "/en/info-centre/glossary/entry/host/", "/en/info-centre/glossary/entry/protein/", "/en/info-centre/glossary/entry/host/", "/en/info-centre/glossary/entry/protein/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/bacteria/", "/en/info-centre/glossary/entry/amino-acid/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/sars/", "/en/info-centre/glossary/entry/pandemic/", "/en/info-centre/glossary/entry/sars/", "/en/info-centre/glossary/entry/sars/", "/en/info-centre/glossary/entry/antibodies/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/sars/", "/en/info-centre/glossary/entry/rna/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/sars/", "/en/info-centre/glossary/entry/pandemic/", "/en/info-centre/glossary/entry/pandemic/", "/en/info-centre/glossary/entry/pandemic/", "/en/info-centre/glossary/entry/pandemic/", "/en/info-centre/glossary/entry/pandemic/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/who/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/infection/", "/en/press/videos-podcasts/videos/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/entry/sars/", "/en/info-centre/glossary/entry/infection/", "/en/info-centre/glossary/entry/protein/", "/en/info-centre/glossary/entry/protein/", "/en/press/videos-podcasts/videos/", "javascript:if(window.print)window.print()", "mailto:?subject=&body=https://www.helmholtz-hzi.de/en/press/videos-podcasts/videos/detail/article/-fccb893ff2/72/", "https://www.facebook.com/sharer/sharer.php?u=https://www.helmholtz-hzi.de/en/press/videos-podcasts/videos/detail/article/-fccb893ff2/72/%2F&src=sdkpreparse", "https://twitter.com/intent/tweet?text=Check%20this%20page%20https://www.helmholtz-hzi.de/en/press/videos-podcasts/videos/detail/article/-fccb893ff2/72/", "/en/press/", "https://buendnis.niedersachsen.de/startseite/", "https://www.helmholtz-klima.de/en", "https://www.charta-der-vielfalt.de/en/", "https://www.initiative-transparente-tierversuche.de/", "https://www.facebook.com/helmholtz.hzi", "https://twitter.com/Helmholtz_HZI", "https://de.linkedin.com/company/helmholtz-centre-for-infection-research", "https://www.youtube.com/channel/UC1P_GFvzrKeCgD4z4h4sKDQ", "/en/service/feeds/", "/en/service/newsletter/", "tel:+495316181-0", "/en/nc/service/contact/person/helmholtz-centre-for-infection-research-hzi/", "tel:+49531-6181-0", "/en/nc/service/contact/person/helmholtz-centre-for-infection-research-hzi/", "/en/the-hzi/sites/campus-braunschweig/", "tel:+49-531-391-55100", "/en/nc/service/contact/person/braunschweig-integrated-centre-of-systems-biology-brics/", "/en/the-hzi/sites/braunschweiger-integrated-centre-of-systems-brics/about-brics/", "tel:+49-511-220027-0", "/en/nc/service/contact/person/twincore-centre-for-experimental-and-clinical-infection-research/", "/en/the-hzi/sites/twincore-centre-for-experimental-and-clinical-infection-research/about-twincore/", "tel:+49-511-5350-8500", "/en/nc/service/contact/person/hzi-study-centre/", "/en/the-hzi/sites/study-centre-crc/", "tel:+49-511-5350-8658", "/en/nc/service/contact/person/centre-for-individualised-infection-medicine-ciim/", "/en/the-hzi/sites/centre-for-individualised-infection-medicine-ciim/", "tel:+49-40-8998-3672", "/en/nc/service/contact/person/centre-for-structural-systems-biology-cssb/", "/en/the-hzi/sites/centre-for-structural-systems-biology-cssb/", "tel:+49-681-98806-0", "/en/nc/service/contact/person/helmholtz-institute-for-pharmaceutical-research-saarland-hips/", "/en/the-hzi/sites/helmholtz-institute-for-pharmaceutical-research-saarland-hips/about-hips/", "tel:+49-931-31-89587", "mailto:info@helmholtz-hiri.de", "/en/the-hzi/sites/helmholtz-institute-for-rna-based-infection-research-hiri/", "tel:+49-3834-420-5501", "mailto:hioh-info@helmholtz-hzi.de", "/en/the-hzi/sites/helmholtz-institute-for-one-health-hioh/", "/en/the-hzi/sites/campus-braunschweig/", "/en/the-hzi/sites/braunschweiger-integrated-centre-of-systems-brics/about-brics/", "/en/the-hzi/sites/helmholtz-institute-for-pharmaceutical-research-saarland-hips/about-hips/", "/en/the-hzi/sites/twincore-centre-for-experimental-and-clinical-infection-research/about-twincore/", "/en/the-hzi/sites/study-centre-crc/", "/en/the-hzi/sites/centre-for-individualised-infection-medicine-ciim/", "/en/the-hzi/sites/centre-for-structural-systems-biology-cssb/", "/en/the-hzi/sites/helmholtz-institute-for-one-health-hioh/", "/en/the-hzi/sites/helmholtz-institute-for-rna-based-infection-research-hiri/", "/en/nc/service/contact/", "/en/service/imprint/", "/en/service/sitemap/", "/en/service/newsletter/", "/en/service/data-protection/", "https://whistlefox.heuking.de/start/hzi-gmbh/en", "https://www.helmholtz.de"]}